A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

Nature

Volumn 413, Issue 6855, 2001, Pages 531-534

  Miyamoto, K ^a   Miyake, S ^a   Yamamura, T ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASE CONTROL; LIPIDS;

REGULARITY CELLS;

NEUROLOGY;

ALPHA GALACTOSYLCERAMIDE; ALPHA GALACTOSYLCERAMIDE DERIVATIVE; CD1D ANTIGEN; CERAMIDE DERIVATIVE; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 4; RECEPTOR SUBTYPE; SPHINGOSINE DERIVATIVE; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

MEDICINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG TARGETING; IMMUNOSUPPRESSIVE TREATMENT; LIGAND BINDING; MOUSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; T LYMPHOCYTE ACTIVATION; TH2 CELL; TREATMENT OUTCOME;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD1; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GALACTOSYLCERAMIDES; GLYCOLIPIDS; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE SUBSETS; MICE; MOLECULAR SEQUENCE DATA; TH2 CELLS;

EID: 0035807302     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35097097     Document Type: Article

References (21)

1. Manipulation of the Th1/Th2 balance in autoimmune disease
2. Regulatory T cells specific for the same framework 3 region of the Vβ8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis
3. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells
4. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
5. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
6. CD1d-mediated recognition of α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution
7. Natural T cells. Cells that co-express NKRP-1 and TCR
8. Mouse CDl-specific NK1 T cells: Development, specificity and function
9. NKT cells: Facts, functions and fallacies
10. Tracking the response of natural killer T cells to a glycolipid antigen using CDld tetramer
11. A The molecular basis of CDl-mediated presentation of lipid antigens
12. +NK T cells associated with disease development in autoimmune-prone mice
13. -(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)4 and/or IL-10
14. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis
15. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
16. Differential expression of natural killer T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy
17. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα 14 NK T cells
18. Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology
19. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
20. An unexpected version of horror autotoxicus: Anaphylactic shock to a self-peptide
21. Synthesis of α-,β-monoglycosylceramides and four diastereomers of an αgalactosylceramide